HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral misoprostol for third stage of labor: a randomized placebo-controlled trial.

AbstractOBJECTIVE:
To investigate whether orally administered misoprostol during the third stage of labor is efficient in reducing postpartum blood loss.
METHODS:
In a double-masked trial, during vaginal delivery women were randomly assigned to receive a single oral dose of misoprostol (600 microg) or placebo in third stage of labor, immediately after cord clamping. The third stage of labor was managed routinely by early cord clamping and controlled cord traction; oxytocin was administered only if blood loss seemed more than usual. Blood loss was estimated by the delivering physician and differences in hematocrit were measured before and after delivery.
RESULTS:
Mean (+/- standard error of the mean) estimated blood loss (345 +/- 19.5 mL versus 417 +/- 25.9 mL, P = .031) and hematocrit difference (4.5 +/- 0.9% versus 7.9 +/- 1.2%, P = .014) were significantly lower in women who received misoprostol than those who received placebo. Fewer women in the misoprostol group had postpartum hemorrhage (blood loss of at least 500 mL), but that difference was not statistically significant (7% versus 15%, P = .43). Additional oxytocin before or after placental separation was used less often in the misoprostol group (16% versus 38%, P = .047). There were no differences in the length of third stage of labor (8 +/- 0.9 minutes versus 9 +/- 1 minutes, P = .947). There were no differences in pain during third stage of labor, postpartum fever, or diarrhea, but shivering was more frequent in the misoprostol group.
CONCLUSION:
Oral misoprostol administered in the third stage of labor reduced postpartum blood loss and might be effective in reducing incidence of postpartum hemorrhage.
AuthorsD V Surbek, P M Fehr, I Hösli, W Holzgreve
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 94 Issue 2 Pg. 255-8 (Aug 1999) ISSN: 0029-7844 [Print] United States
PMID10432138 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Misoprostol
Topics
  • Administration, Oral
  • Adult
  • Double-Blind Method
  • Female
  • Humans
  • Labor Stage, Third
  • Misoprostol (therapeutic use)
  • Postpartum Hemorrhage (prevention & control)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: